The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial.

BMC Pulmonary Medicine
Annemarie L LeeSue Jenkins

Abstract

Non-cystic fibrosis bronchiectasis is characterised by sputum production, exercise limitation and recurrent infections. Although pulmonary rehabilitation is advocated for this patient group, its effects are unclear. The aims of this study are to determine the short and long term effects of pulmonary rehabilitation on exercise capacity, cough, quality of life and the incidence of acute pulmonary exacerbations. This randomised controlled trial aims to recruit 64 patients with bronchiectasis from three tertiary institutions. Participants will be randomly allocated to the intervention group (supervised, twice weekly exercise training with regular review of airway clearance therapy) or a control group (twice weekly telephone support). Measurements will be taken at baseline, immediately following the intervention and at six and 12 months following the intervention period by a blinded assessor. Exercise capacity will be measured using the incremental shuttle walk test and the six-minute walk test. Quality of life and health status will be measured using the Chronic Respiratory Questionnaire, Leicester Cough Questionnaire, Assessment of Quality of Life Questionnaire and the Hospital Anxiety and Depression Scale. The rate of hospitalisa...Continue Reading

References

Mar 1, 1988·Chest·D A Mahler, C K Wells
Jan 1, 1982·Medicine and Science in Sports and Exercise·G A Borg
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·C B WilsonR Wilson
Jun 13, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J Bousquet
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
Jul 26, 2002·The Cochrane Database of Systematic Reviews·J BradleyM Greenstone
May 27, 2003·The European Respiratory Journal·N G KoulourisJ Jordanoglou
Aug 14, 2003·Health and Quality of Life Outcomes·R Philip Snaith
Jan 11, 2005·The European Respiratory Journal·H J SchünemannG H Guyatt
May 27, 2005·Australian and New Zealand Journal of Public Health·Graeme Hawthorne, Richard Osborne
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Aug 16, 2005·Chest·Miguel Angel Martínez-GarcíaJuan José Soler-Cataluña
May 3, 2006·Respiratory Medicine·Paul T KingPeter W Holmes
Jun 9, 2006·American Journal of Respiratory and Critical Care Medicine·Linda NiciUNKNOWN ATS/ERS Pulmonary Rehabilitation Writing Committee
Dec 2, 2006·COPD·Paul T KingPeter W Holmes
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Jan 2, 2008·The European Respiratory Journal·E D BatemanH J Zar
Aug 1, 2008·Australian Health Review : a Publication of the Australian Hospital Association·Nola CecinsSue C Jenkins
Dec 17, 2008·Respiratory Medicine·A L LeeL Denehy
Feb 7, 2009·The European Respiratory Journal·M P MurrayA T Hill
Apr 10, 2009·The European Respiratory Journal·M R LoebingerR Wilson
Jun 18, 2009·Current Opinion in Pulmonary Medicine·Peter A Coventry
Jun 19, 2009·The New England Journal of Medicine·Luis M Seijo
Aug 8, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kenneth W Tsang, Diana Bilton
Sep 17, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Annemarie L LeeJohn W Wilson

❮ Previous
Next ❯

Citations

Oct 6, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sue JenkinsNola M Cecins
Sep 11, 2012·Multidisciplinary Respiratory Medicine·Ozge OzalpLutfi Coplu
Oct 12, 2012·Stem Cell Reviews and Reports·Carolina Arruda de FariaJoão Tadeu Ribeiro-Paes
Sep 6, 2012·Chest·Roger S GoldsteinThomas E Dolmage
Aug 11, 2011·Pediatric Pulmonology·Nitin KapurAnne B Chang
Dec 24, 2013·Archives of Physical Medicine and Rehabilitation·Anderson Alves de CamargoSimone Dal Corso
Nov 3, 2015·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Gabriel OlveiraRocío Martín-Valero
Jun 17, 2015·International Journal of Immunopathology and Pharmacology·D SnijdersA Barbato
Nov 4, 2017·Medical Sciences : Open Access Journal·Caroline H NicolsonAnnemarie L Lee
Feb 8, 2018·The Cochrane Database of Systematic Reviews·Carol KellySally Spencer

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00885521

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.